Mel Sorensen Galera Therapeutics, Inc. (GRTX) insider trading activity
Mel Sorensen is President and CEO of Galera Therapeutics, Inc.. Currently has a direct ownership of 195,029 shares of GRTX, which is worth approximately $3,900. The most recent transaction as insider was on Nov 20, 2025, when has been sold 70,000 shares (Common Stock) at a price of $0.02 per share, resulting in proceeds of $1,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
195K
26.41%
3M change
26.41%
12M change
Total Value Held
$3,900
Mel Sorensen Transaction History
MS
Mel Sorensen
President and CEO
Malvern, PA